EVOKE PHARMA, INC. Preferred Stock, Par or Stated Value Per Share
EVOKE PHARMA, INC. had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2025-11-13
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2025-06-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2025-03-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2024-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 10-K/A · filed 2024-05-14 |
| 2023-06-30 | $0.00 10-K/A · filed 2024-05-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-K/A · filed 2024-05-14 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-21 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-08 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-06 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-07 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-04 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-13 |